With appropriate introduction of oral appliance therapy, more patients are seeing success in navigating sleep disorders and other comorbidities.

Before the rise of GLP-1s, obesity experts didn’t study the internal buzz that compels people to eat. Now that food noise is ...

The SYNCHRONIZE-1 trial evaluated survodutide in non-diabetic adults with obesity or overweight with at least 1 weight-related complication.

High blood pressure is often framed like a personal failure. Eat better, move more, sleep well, take the pills. But a newer ...

I spoke with a doctor at Apple to learn more about the Apple Watch health features that you might not currently be using to ...

Researchers are exploring drugs like Ozempic, Mounjaro, and Wegovy to treat or prevent a range of conditions, including ...

For years, a daily nap has been treated as one of the small comforts of getting older. But a study published in early 2026 in ...

GLP-1 medications that suppress appetite are allowing people to better manage diabetes and obesity. As weight-loss drug ...

As next generation antiobesity medications (AOMs) take the culture by storm, many providers and researchers are asking an important question: how are distinct subsets of the population differently ...

Can at-home vagus nerve stimulators deliver on the lofty promises to improve sleep, stress, and anxiety? We tested them and ...

Wegovy (semaglutide) and Zepbound (tirzepatide) are commonly prescribed medications for weight management. Semaglutide, the ...

Could you provide an overview of the Develop hypersomnia Understanding by Evaluating low-sodium oxybate Treatment (DUET) ...